Seed VC · USA

Takeda Ventures

Active

What they invest in

Takeda Ventures is the corporate venture capital group founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments, focusing on high-caliber, therapeutic, platform-based companies that complement Takeda's pipeline in areas aligned with its R&D pillars: Oncology, Rare Genetics, and other therapeutic areas.

Who they back

DeepTechHealthtechBiotechLife science only (OncologyGastroenterologyNeuroscienceand Rare Disease)SeedSeries ASeries B+

Business models

deeptech_ip, biotech_therapeutics

Customer segments

Researchers

Geography

US, Europe, APAC

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Takeda Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Takeda Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Portfolio last checked
Oct 6, 2026
Website
www.takeda.com/what-we-do/research-and-development/rd-partnering/center-for-external-innovation/takeda-ventures ↗

Other firms investing in DeepTech

See all investors

Is Takeda Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Takeda Ventures is one of them, and we'll tell you exactly where they sit in your top 100.